Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$34.88 - $43.22 $785,148 - $972,882
-22,510 Reduced 21.9%
80,264 $3.03 Million
Q4 2022

Feb 14, 2023

BUY
$33.8 - $47.06 $3.47 Million - $4.84 Million
102,774 New
102,774 $4.36 Million
Q2 2022

Aug 15, 2022

SELL
$26.83 - $38.57 $4.33 Million - $6.22 Million
-161,210 Reduced 77.93%
45,652 $1.48 Million
Q1 2022

May 16, 2022

BUY
$30.95 - $39.68 $1.35 Million - $1.73 Million
43,524 Added 26.65%
206,862 $7.48 Million
Q4 2021

Feb 14, 2022

BUY
$35.87 - $47.12 $5.37 Million - $7.05 Million
149,659 Added 1094.08%
163,338 $6.46 Million
Q3 2021

Nov 15, 2021

SELL
$41.55 - $48.72 $599,026 - $702,396
-14,417 Reduced 51.31%
13,679 $598,000
Q2 2021

Aug 16, 2021

BUY
$32.88 - $44.57 $290,626 - $393,954
8,839 Added 45.9%
28,096 $1.15 Million
Q1 2021

May 17, 2021

SELL
$30.92 - $44.4 $1.39 Million - $2 Million
-45,085 Reduced 70.07%
19,257 $632,000
Q4 2020

Feb 16, 2021

SELL
$33.66 - $40.76 $1.03 Million - $1.25 Million
-30,739 Reduced 32.33%
64,342 $2.62 Million
Q3 2020

Nov 10, 2020

BUY
$33.07 - $38.68 $3.14 Million - $3.68 Million
95,081 New
95,081 $3.48 Million
Q2 2020

Aug 14, 2020

SELL
$20.05 - $33.89 $803,784 - $1.36 Million
-40,089 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$17.15 - $25.22 $687,526 - $1.01 Million
40,089 New
40,089 $849,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.